Altimmune (ALT) Change in Account Payables (2010 - 2026)
Altimmune's (ALT) quarterly Change in Account Payables came in at -$1.2 million in Q1 2026, down 237.07% year-on-year from $866000.0 in Q1 2025, and up 43.12% on a QoQ basis from -$2.1 million in Q4 2025.
Altimmune (ALT) Change in Account Payables (2010 - 2026) Analysis & Trends
Altimmune (ALT) has 17 years of Change in Account Payables data on file, last reported at -$1.2 million in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 237.07% year-over-year to -$1.2 million in Q1 2026; TTM through Mar 2026 was $453000.0, a 116.88% increase from a year earlier, with the FY2025 full-year figure at $2.5 million, up 234.8% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$1.2 million, up from -$2.1 million in the prior quarter.
- Over the last five years, Change in Account Payables for ALT reached as high as $4.0 million in Q3 2025 and fell as low as -$2.1 million in Q4 2025.
- Historically, Change in Account Payables has averaged -$29647.1 across 5 years, with a median of -$922000.0 in 2024.
- Across the five-year window, Change in Account Payables tumbled 280.36% in 2023 and jumped 354.21% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at $3.4 million in 2022, then slumped by 128.83% to -$976000.0 in 2023, then gained by 5.53% to -$922000.0 in 2024, then plunged by 126.36% to -$2.1 million in 2025, then jumped by 43.12% to -$1.2 million in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$1.2 million in Q1 2026, -$2.1 million in Q4 2025, and $4.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - | -1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.19 Mn |
| Mar 31, 2026 | -1.19 Mn |
| Dec 31, 2025 | -2.09 Mn |
| Dec 31, 2025 | -2.09 Mn |
| Sep 30, 2025 | 3.95 Mn |
| Sep 30, 2025 | 3.95 Mn |
| Jun 30, 2025 | -226,000.00 |
| Jun 30, 2025 | -226,000.00 |
| Mar 31, 2025 | 866,000.00 |
| Mar 31, 2025 | 866,000.00 |
| Dec 31, 2024 | -922,000.00 |
| Dec 31, 2024 | -922,000.00 |
| Sep 30, 2024 | -1.56 Mn |
| Sep 30, 2024 | -1.56 Mn |
| Jun 30, 2024 | -1.07 Mn |
| Jun 30, 2024 | -1.07 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | -976,000.00 |
| Dec 31, 2023 | -976,000.00 |